4MOVING BIOTECH

4MOVING BIOTECH is a biotech startup company that focuses on the development of 4P004, a GLP-1 analog and an innovative candidate drug designed to meet unmet medical needs. Its aim is to alter the natural course of osteoarthritis, thereby preventing the disease over the long term. Additionally, it can reduce the secretion of inflammatory cytokines and degrading enzymes within joint tissues, offering powerful anti-inflammatory and anti-degradative properties.